Liver toxicity associated with sofosbuvir, an NS5A inhibitor and ribavirin use

Journal of Hepatology
Jessica K DysonStuart McPherson

Abstract

Hepatitis C virus (HCV) infection is a major cause of end-stage liver disease and hepatocellular carcinoma. There have been rapid advances in HCV treatment with the development of oral direct-acting antivirals (DAAs). Studies have shown sustained virological response rates above 90% with combinations of DAAs, including patients with compensated cirrhosis. Thus far, significant drug toxicity has not been seen with these agents, but there is limited experience of using DAAs in decompensated HCV cirrhosis. This report describes the first experience of serious drug-induced hepatotoxicity with the new DAAs. The mechanism underlying these drug reactions is currently unknown. Few patients with decompensated cirrhosis have been treated with DAAs, so the exact pharmacokinetics in this population have not been characterised. In both cases presented here, patients were taking or had recently taken other drugs. It is possible that an unknown interaction or reaction to the drug combination caused the hepatotoxicity. Although the association with the DAAs is not proven these cases indicate that patients with advanced liver disease need close monitoring while on DAA therapy and if there is a significant unexplained deterioration in liver func...Continue Reading

References

Sep 1, 1993·Journal of Internal Medicine·A Lindgren, R Olsson
Jun 2, 2009·Nature Genetics·Ann K DalyUNKNOWN International SAE Consortium
Nov 10, 2013·Drug Design, Development and Therapy·Choongho Lee
Jan 7, 2014·Mayo Clinic Proceedings·Michael D LeiseJayant A Talwalkar
Apr 15, 2014·The New England Journal of Medicine·Nezam AfdhalUNKNOWN ION-2 Investigators

❮ Previous
Next ❯

Citations

Nov 26, 2015·Expert Opinion on Pharmacotherapy·Vincent SorianoPablo Barreiro
Feb 2, 2016·Journal of Hepatology·Graham R FosterUNKNOWN HCV Research, UK
Dec 15, 2015·Journal of Hepatology·Martin-Walter WelkerChristoph Sarrazin
Apr 20, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Rolf Teschke, Gaby Danan
May 6, 2016·Expert Opinion on Pharmacotherapy·Laura Benítez-GutiérrezVicente Soriano
May 27, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T C Wirth, M P Manns
Sep 20, 2016·Journal of Hepatology·Jordan J Feld, Graham R Foster
Jul 13, 2016·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Raoel MaanJordan J Feld
Oct 16, 2016·Transplantation Proceedings·L Benítez-GutiérrezV Cuervas-Mons
Nov 9, 2016·Expert Opinion on Drug Metabolism & Toxicology·Rolf Teschke, Gaby Danan
Nov 24, 2016·Expert Opinion on Drug Safety·Cristina ScavoneAnnalisa Capuano
Feb 9, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Carlos Fernández CarrilloJosé Luis Calleja
May 10, 2017·Expert Review of Gastroenterology & Hepatology·Aisha ElsharkawyGamal Esmat
Jul 7, 2017·CA: a Cancer Journal for Clinicians·Harrys A TorresVincent Mallet
Dec 3, 2017·Liver International : Official Journal of the International Association for the Study of the Liver·Sandra BeinhardtHarald Hofer
May 6, 2016·Nature Reviews. Gastroenterology & Hepatology·Matthias Götte, Jordan J Feld
Dec 30, 2015·International Journal of Molecular Sciences·Gaby Danan, Rolf Teschke
Mar 2, 2016·Current Opinion in Organ Transplantation·Tianyan Chen, Norah A Terrault
May 22, 2020·Journal of Medical Virology·Dandan Tian, Qing Ye
Feb 25, 2017·Current Opinion in Gastroenterology·Eric G Meissner
Apr 27, 2017·World Journal of Hepatology·Tamara AlempijevicTomica Milosavljevic
Feb 16, 2019·Current Hepatology Reports·Priya Grewal, Jawad Ahmad
Jan 2, 2019·World Journal of Gastroenterology : WJG·Hu LiZong-Gen Peng
Sep 29, 2017·Clinical Liver Disease·Rajani Sharma, Robert S Brown
Sep 15, 2019·International Journal of Biological Macromolecules·Noha H Habashy, Marwa M Abu-Serie
Sep 7, 2017·The American Journal of Gastroenterology·Raymond S Koff
Jan 18, 2020·Current Molecular Pharmacology·Sherin Zakaria, Alaa E El-Sisi
Oct 19, 2016·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Pengcheng OuJun Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

BMJ : British Medical Journal
Eoin R Feeney, Raymond T Chung
Liver International : Official Journal of the International Association for the Study of the Liver
Vincenzo Boccaccio, Savino Bruno
© 2021 Meta ULC. All rights reserved